egtazic acid has been researched along with Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bornstein, N; Diener, HC; Gorelick, PB; Lees, K; Rosenberg, G; Shuaib, A | 1 |
Arba, F; Balami, JS; Buchan, AM; Kleinschnitz, C; Minnerup, J; Sutherland, BA | 1 |
Bornstein, N; Diener, HC; Gorelick, PB; Lees, KR; Rosenberg, G; Shuaib, A | 1 |
1 review(s) available for egtazic acid and Stroke
Article | Year |
---|---|
Neuroprotection for ischaemic stroke: translation from the bench to the bedside.
Topics: Acute Disease; Animals; Benzenesulfonates; Brain Ischemia; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Diffusion of Innovation; Disease Models, Animal; Drug Evaluation, Preclinical; Egtazic Acid; Hematopoietic Cell Growth Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothermia, Induced; Magnesium; Minocycline; NADPH Oxidases; Neuroprotective Agents; Pregnatrienes; Serum Albumin; Stroke; Thrombolytic Therapy; Translational Research, Biomedical | 2012 |
2 trial(s) available for egtazic acid and Stroke
Article | Year |
---|---|
The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Double-Blind Method; Egtazic Acid; Female; Humans; Male; Middle Aged; Research Design; Stroke; Young Adult | 2011 |
Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Egtazic Acid; Endpoint Determination; Female; Humans; Male; Middle Aged; Severity of Illness Index; Stroke; Time Factors; Treatment Outcome | 2013 |